Cyclosporine treatment of acquired hemophilia due to factor VIIi antibodies
Petrovic, M.; Derom, E.; Baele, G.
Haematologica 85(8): 895-896
2000
ISSN/ISBN: 0390-6078 PMID: 10942956 Document Number: 514871
Document emailed within 1 workday
Related Documents
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27Lopaciuk, S.; Ziemski, J.M. 1979: Treatment of patients with hemophilia a having antibodies to factor VIIi Acta Haematologica Polonica 10(2): 115-122
Lottenberg, R.; Kentro, T.B.; Kitchens, C.S. 1987: Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy Archives of Internal Medicine 147(6): 1077-1081
Klukowska, A.; Adamowicz-Salach, A.; Kamińska, D.; Zieleniewska, B. 1987: Anti-factor VIIi antibodies in children with hemophilia, and the management of hemorrhage Polski Tygodnik Lekarski 42(30): 911-914
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Mauser-Bunschoten, E.P.; Damen, M.; Reesink, H.W.; Roosendaal, G.; Chamuleau, R.A.; van den Berg, H.M. 1996: Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C Annals of Internal Medicine 125(4): 297-299
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Fijnvandraat, K.; Berntorp, E.; ten Cate, J.W.; Johnsson, H.; Peters, M.; Savidge, G.; Tengborn, L.; Spira, J.; Stahl, C. 1997: Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients Thrombosis and Haemostasis 77(2): 298-302
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Kunst, V.A.; Nováková, I.R.; Haanen, C. 1989: Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A Nederlands Tijdschrift Voor Geneeskunde 133(23): 1163-1166
Gatti, L.; Mannucci, P.M. 1984: Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies Thrombosis and Haemostasis 51(3): 379-384
Walker, I.; Poon, M.C. 1992: Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group Lancet 339(8784): 61-62
Mauser-Bunschoten, E.P.; Roosendaal, G.; Bruin, M.; van Dijken, P.J. 1990: Disappearance of factor VIIi antibodies upon frequent administration of factor VIIi Folia Haematologica 117(4): 533-537
Mahasandana, C.; Patharathienskul, D.; Suvatte, V. 1993: Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management Southeast Asian Journal of Tropical Medicine and Public Health 24(Suppl 1): 106-112
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Evensen, S.A.; Stavem, P.; Stormorken, H.; Glomstein, A.; Ly, B. 1986: Treatment of hemophiliacs with antibodies to factor VIIi Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(1): 35-38
Schoppmann, A.; Waytes, A.T. 1996: Factor VIIi inhibitor and severity of hemophilia Thrombosis and Haemostasis 76(2): 280-281
Bolland, J.; Lambotte, C. 1978: Factor VIIi in hemophilia and von Willebrand's disease Revue Medicale de Liege 33(8): 284-295